Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

D. Lievens · SciRah

Researcher profile · Semantic Scholar

D. Lievens

Share profile

D. Lievens — researcher profile on SciRah

h-index: 6
Works: 21
Citations: 109

Most-cited papers

Economic consequences of legal and illegal drugs: The case of social costs in Belgium.
D. Lievens, Freya Vander Laenen, N. Verhaeghe, K. Putman +3 more
2017The International journal on drug policy26 citations
Semantic Scholar
The health-related social costs of alcohol in Belgium
N. Verhaeghe, D. Lievens, L. Annemans, Freya Vander Laenen +1 more
2017BMC Public Health24 citations Open access
Semantic Scholar
Public spending for illegal drug and alcohol treatment in hospitals: an EU cross-country comparison
D. Lievens, Freya Vander Laenen, J. Christiaens
2014Substance Abuse Treatment, Prevention, and Policy16 citations Open access
Semantic Scholar
Methodological Considerations in Social Cost Studies of Addictive Substances: A Systematic Literature Review
N. Verhaeghe, D. Lievens, L. Annemans, Freya Vander Laenen +1 more
2017Frontiers in Public Health12 citations Open access
Semantic Scholar
The social cost of legal and illegal drugs in Belgium
F. V. Laenen, D. Lievens, L. Pauwels, Wim Hardyns +4 more
201610 citations
Semantic Scholar
Studies on public drug expenditure in Europe, possibilities and limitations
F. V. Laenen, L. Vandam, B. De Ruyver, D. Lievens
201110 citations
Semantic Scholar
Drugs in figures III: study of public expenditures on drug control and drug problems
D. Lievens, F. V. Laenen, J. Caulkins, B. De Ruyver
20124 citations
Semantic Scholar
Efficacy and Safety of Nintedanib in Elderly Patients with Progressive Fibrosing Interstitial Lung Diseases (ILDs)
F. Bonella, T. Moua, M. Okamoto, S. Tomassetti +5 more
2022B22. EMERGING MANAGEMENT OF FIBROTIC ILDs2 citations
Semantic Scholar
Associations Between Semi-quantitative HRCT Features and Outcomes in Patients With IPF: Data From the INPULSIS Trials
J. Jacob, A. Wells, N. Sverzellati, L. Richeldi +5 more
2023A23. LEVERAGING IMAGING AND BIOSAMPLES TO IMPROVE DIAGNOSIS AND RISK PREDICTION IN ILA AND ILD1 citations
Semantic Scholar
Literature survey on the methods used to estimate public expenditure on illicit drug treatment in Europe and beyond
F. V. Laenen, D. Lievens
20131 citations
Semantic Scholar
An analysis of the Belgian public expenditure study ‘Drugs in Figures III’: exploring the potential roles for drug policy
D. Lievens, F. V. Laenen, Jonathan Caulkin, B. De Ruyver
20121 citations
Semantic Scholar
Drugs in Figures III
D. Lievens, F. V. Laenen, J. Caulkins, B. De Ruyver
20121 citations
Semantic Scholar
Effects of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis and Varying Severities of Cough
W. Wuyts, C. Vancheri, F. Bonella, A. Russell +3 more
TP28. TP028 APPROACH TO THERAPY IN FIBROSING AND NON-FIBROSING ILD1 citations Open access
Semantic Scholar
Effect of Nintedanib in Patients With Idiopathic Pulmonary Fibrosis and Differing Extents of Emphysema on HRCT
V. Cottin, J. Jacob, N. Sverzellati, L. Richeldi +5 more
2023A102. THE DEVELOPMENT, PROGRESSION, AND TREATMENT OF ILD0 citations
Semantic Scholar
Effects of nintedanib in patients with idiopathic pulmonary fibrosis and varying severities of cough*
F. Bonella, W. Wuyts, C. Vancheri, A. Russell +3 more
202262. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V.0 citations
Semantic Scholar
Nintedanib in patients with progressive fibrosing ILDs in subgroups by comorbidity burden
E. Bendstrup, T. Moua, M. Okamoto, S. Tomassetti +5 more
202212.01 - Idiopathic interstitial pneumonias0 citations
Semantic Scholar
A methodology for an EU cross-country comparison? Public expenditure on drug treatment in hospitals
D. Lievens, F. V. Laenen
20170 citations
Semantic Scholar
A cross-national comparison of public expenditures on drug treatment : context is key
F. V. Laenen, D. Lievens
20170 citations
Semantic Scholar
The socio-economic costs of drug use
D. Lievens, F. V. Laenen
20160 citations
Semantic Scholar
Methodological considerations in estimating the public expenditures related to health for addictive substances: a literature review
N. Verhaeghe, L. Annemans, D. Lievens, F. V. Laenen +1 more
20150 citations
Semantic Scholar
The governmental supervision and management of expenditures regarding the realisation and evaluation of drug policy
D. Lievens
20150 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

F. V. Laenen×10
Invite
F. V. Laenen — researcher profile on SciRah
N. Verhaeghe×5
Invite
N. Verhaeghe — researcher profile on SciRah
K. Putman×5
Invite
K. Putman — researcher profile on SciRah
L. Annemans×5
Invite
L. Annemans — researcher profile on SciRah

Freya Vander Laenen

×4

Invite

Freya Vander Laenen — researcher profile on SciRah

B. De Ruyver×4

Invite

B. De Ruyver — researcher profile on SciRah

E. Bendstrup×4

Invite

E. Bendstrup — researcher profile on SciRah

Invite

W. Stansen — researcher profile on SciRah

Invite

W. Wuyts — researcher profile on SciRah

Invite

L. Pauwels — researcher profile on SciRah

Invite

Wim Hardyns — researcher profile on SciRah

Invite

J. Caulkins — researcher profile on SciRah